Fox Run Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,839
Closed -$231K 1094
2026
Q1
$231K Buy
+2,839
New +$233K 0.04% 713
2025
Q3
Sell
-8,738
Closed -$915K 1055
2025
Q2
$915K Buy
+8,738
New +$828K 0.15% 220
2022
Q3
Sell
-8,249
Closed -$506K 705
2022
Q2
$506K Buy
+8,249
New +$528K 0.25% 113
2020
Q3
Sell
-3,667
Closed -$215K 240
2020
Q2
$215K Buy
+3,667
New +$203K 0.28% 192
2019
Q3
Sell
-3,409
Closed -$223K 454
2019
Q2
$223K Buy
3,409
+187
+6% +$13K 0.15% 334
2019
Q1
$238K Buy
+3,222
New +$227K 0.13% 345
2018
Q3
Sell
-3,295
Closed -$247K 678
2018
Q2
$247K Buy
+3,295
New +$237K 0.08% 505
2017
Q1
Sell
-10,700
Closed -$434K 654
2016
Q4
$434K Buy
+10,700
New +$414K 0.23% 175

Other funds holding HQY

Fox Run Management's HQY Position: Q2 2026 in Review

Fox Run Management sold out of HealthEquity (HQY) in Q2 2026, closing a stake of 2,839 shares — an estimated $231K sold.

Fox Run Management first reported a position in HQY in Q4 2016 and held it in 8 quarters. The position peaked at $915K in Q2 2025. 496 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Fox Run Management reported no remaining HealthEquity position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 2,839 HealthEquity shares in Q2 2026, an estimated $231K.
  • Fox Run Management first reported a position in HealthEquity in Q4 2016 and held it in 8 quarters.
  • Fox Run Management's HealthEquity position peaked at $915K in Q2 2025.
  • 496 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.